The Legislative Advocacy Committee oversees ASAM’s Government Relations Program and its activities.

LEGISLATIVE ADVOCACY COMMITTEE

The Legislative Advocacy Committee (LAC) oversees ASAM’s Government Relations Program and its activities. Primarily, this oversight includes Legislative Days on Capitol Hill for ASAM members, ASAM-sponsored events for Congressional leaders and staff on Capitol Hill, cosponsoring similar events initiated by affiliate organizations, working within coalitions, endorsing, and/or reviewing letters of support for or opposition to, particular Congressional bills or Administrative actions (subject to the primary federal regulatory agency jurisdiction of ASAM’s Practice Management and Regulatory Affairs Committee (PMRAC), monitoring state and federal policies that impact access to addiction treatment, and federal grassroots lobbying initiatives.

Primarily, this oversight includes Legislative Days on Capitol Hill for ASAM members, ASAM-sponsored events for Congressional leaders and staff on Capitol Hill, cosponsoring similar events initiated by affiliate organizations, working within coalitions, endorsing, and/or reviewing letters of support for or opposition to, particular Congressional bills or Administrative actions (subject to the primary federal regulatory agency jurisdiction of ASAM’s Practice Management and Regulatory Affairs Committee (PMRAC), monitoring state and federal policies that impact access to addiction treatment, and federal grassroots lobbying initiatives.

Membership

Chair
Shawn Ryan, MD, MBA, FASAM


Vice-Chair
Flora Sadri, DO

  • Kelly Clark, MD, MBA, DFAPA, DFASAM
  • Ruchi Fitzgerald, MD
  • Mark Kraus, MD, DFASAM
  • Michelle Lofwall, MD, DFASAM
  • Andrey Ostrovsky, MD
  • Michael Miller, MD, DFASAM
  • Cara Poland, MD, MEd, FACP, DFASAM
  • Andrew Putney, MD, FASAM
  • Ken Roy, MD, DFASAM
  • Stephen Taylor, MD, MPH
  • Corey Waller, MD, MS, FACEP, DFASAM
  • Mellissa Weimer, DO, MCR, FASAM
  • Steve Wyatt, DO, FASAM